Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

InMed Pharmaceuticals (INM) Depreciation Expense (2022 - 2025)

Historic Depreciation Expense for InMed Pharmaceuticals (INM) over the last 4 years, with Q2 2025 value amounting to $12206.0.

  • InMed Pharmaceuticals' Depreciation Expense rose 12437.5% to $12206.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $50204.0, marking a year-over-year increase of 515.91%. This contributed to the annual value of $50204.0 for FY2025, which is 515.69% up from last year.
  • As of Q2 2025, InMed Pharmaceuticals' Depreciation Expense stood at $12206.0, which was up 12437.5% from $12203.0 recorded in Q1 2025.
  • Over the past 5 years, InMed Pharmaceuticals' Depreciation Expense peaked at $14242.0 during Q4 2023, and registered a low of $5440.0 during Q2 2024.
  • Moreover, its 4-year median value for Depreciation Expense was $12209.0 (2024), whereas its average is $11773.0.
  • Per our database at Business Quant, InMed Pharmaceuticals' Depreciation Expense tumbled by 5788.17% in 2024 and then soared by 12437.5% in 2025.
  • Quarter analysis of 4 years shows InMed Pharmaceuticals' Depreciation Expense stood at $8056.0 in 2022, then surged by 76.79% to $14242.0 in 2023, then fell by 14.27% to $12209.0 in 2024, then fell by 0.02% to $12206.0 in 2025.
  • Its last three reported values are $12206.0 in Q2 2025, $12203.0 for Q1 2025, and $12209.0 during Q4 2024.